Compare BLD & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLD | BAX |
|---|---|---|
| Founded | 2015 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 10.2B |
| IPO Year | N/A | N/A |
| Metric | BLD | BAX |
|---|---|---|
| Price | $491.61 | $20.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $439.86 | $25.00 |
| AVG Volume (30 Days) | 290.5K | ★ 8.3M |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 19.67 | N/A |
| Revenue | $5,236,045,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $2.59 | $5.22 |
| Revenue Next Year | $13.84 | $1.98 |
| P/E Ratio | $25.04 | ★ N/A |
| Revenue Growth | N/A | ★ 3.90 |
| 52 Week Low | $266.26 | $17.40 |
| 52 Week High | $509.36 | $37.74 |
| Indicator | BLD | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 63.14 | 53.29 |
| Support Level | $478.04 | $19.36 |
| Resistance Level | $509.36 | $20.46 |
| Average True Range (ATR) | 18.19 | 0.68 |
| MACD | 4.34 | -0.05 |
| Stochastic Oscillator | 80.81 | 41.25 |
TopBuild Corp is an installer and distributor of insulation products. Its operating segments involve the Installation and Specialty Distribution segment. The installation segment provides insulation installation services nationwide through contractor services business. Speciality Distribution segment distributes building and mechanical insulation, insulation accessories and other building product materials for the residential, commercial, and industrial end markets. The majority of revenue is earned from the installation segment. Its main customers are contractors. Other products include gutters, after-paint, garage doors, fireplaces, and fireproofing and stopping. TopBuild operates majorly in the United States.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.